Zdrowie i gospodarka · 15.04.2008
Antimicrobial Resistance; Public Hearing; Request for Comments
The Food and Drug Administration (FDA) is announcing a public hearing on antimicrobial resistance. FDA is seeking general information about the problem of antimicrobial resistance, recommendations as to possible approaches to contain the problem of antimicrobial resistance, responses to specific questions (see section III of this document), and other pertinent information from interested parties. In addition, interested parties may provide views on which serious and life-threatening infectious diseases, such as diseases due to gram-negative bacteria and other diseases due to antimicrobial- resistant bacteria, potentially qualify for available grants and contracts or other development incentives.